PulmCCM

PulmCCM

Home
Notes
Index
Reviews
Physiology
All
Book
About

Cardiology

PE & DVT prevention for cancer patients (API-CAT trial)
Low-dose apixaban worked well, but was it "noninferior"?
 • 
PulmCCM
2025 Guideline on Acute Coronary Syndromes and Myocardial Infarctions
Formal guidance provided on transfusion targets, revascularization, meds and more
 • 
PulmCCM
2
NEW GUIDELINE: Ultrasound should be used to manage almost all critically ill patients
If you're not using ultrasound, are you meeting the standard of care?
 • 
PulmCCM
4
Should age influence duration of CPR for cardiac arrests in the hospital?
Intuition says yes. What does the data say?
 • 
PulmCCM
Beta-blockers for septic shock (Review)
Blunting catecholamine toxicity without causing harm: is it possible?
 • 
PulmCCM
4
How long should CPR be performed for non-shockable cardiac arrests in the hospital?
A series to help inform the final life-and-death decision
 • 
PulmCCM
Guidelines on Red Cell Transfusion (Review)
Recommendations are conservative, but most clinicians are still liberal
 • 
PulmCCM
3
How long should CPR be performed for shockable in-hospital cardiac arrests?
A series to help inform the final life-and-death decision
 • 
PulmCCM
How long should CPR be performed after cardiac arrest in the hospital?
A series to help inform the final life-and-death decision
 • 
PulmCCM
5
New CPR guidelines: What changed?
Post-cardiac arrest oxygen and CO2 targets, seizure prophylaxis, more
 • 
PulmCCM
7
Transfusion in acute MI: what's the right hemoglobin target?
New meta-analysis with three smaller trials adds heft to MINT
 • 
PulmCCM
3
Transcatheter Tricuspid Valve Replacement for Severe Tricuspid Regurgitation (TRISCEND II trial)
Very sick patients took their risk up front with new procedure, and often benefited
 • 
PulmCCM
© 2025 PulmCCM LLC
Substack
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture